Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

KIAA1524 antibody

This Mouse Monoclonal antibody specifically detects KIAA1524 in WB and IP. It exhibits reactivity toward Human.
Catalog No. ABIN1907992
-15% Promotion 2026
$587.80
$691.53
save $103.73 (-15 %)
Plus shipping costs $50.00
Shipping to: United States
Delivery in 11 to 14 Business Days

Quick Overview for KIAA1524 antibody (ABIN1907992)

Target

See all KIAA1524 Antibodies
KIAA1524

Reactivity

  • 42
  • 22
  • 16
  • 1
Human

Host

  • 37
  • 8
Mouse

Clonality

  • 37
  • 8
Monoclonal

Conjugate

  • 25
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This KIAA1524 antibody is un-conjugated

Application

  • 35
  • 8
  • 7
  • 6
  • 6
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunoprecipitation (IP)
  • Specificity

    Human KIAA1524 / p90 Autoantigen

    Purification

    Immunoaffinity purified

    Immunogen

    Amino terminal one-third of the CIP2A (GeneID 57650) recombinant protein.

    Type of Immunogen: Recombinant protein

    Isotype

    IgG1 kappa
  • Application Notes

    Approved: IP (2 - 5 μg/mg lysate), WB (1:5000 - 1:25000)

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Tris-citrate/phosphate buffer,  pH 7-8, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store at 2-8°C for up to 1 year.

    Expiry Date

    12 months
  • Target

    KIAA1524

    Alternative Name

    KIAA1524 / p90 Autoantigen

    Background

    Name/Gene ID: KIAA1524

    Synonyms: KIAA1524, Cancerous inhibitor of PP2A, CIP2A, Protein CIP2A, p90 autoantigen, p90

    Gene ID

    57650
You are here:
Chat with us!